These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

937 related articles for article (PubMed ID: 6139800)

  • 61. [Beta-blocking agents alone or combined with diuretics or alpha-adrenolytics in the treatment of essential arterial hypertension].
    Minutillo S; Lupinc V; D'Agnolo B
    Minerva Med; 1979 Dec; 70(57):3919-24. PubMed ID: 43488
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)].
    Weidmann P; Beretta-Piccoli C; Ziegler W; Hirsch D; de Châtel RD; Reubi FC
    Klin Wochenschr; 1976 Aug; 54(16):765-73. PubMed ID: 8663
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dopamine-beta-hydroxylase after treatment with beta-blockers in hypertension.
    Aberg H; Hedstrand H; Wetterberg L; Ross SB
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):15-8. PubMed ID: 1150360
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The hypotensive effect of propranolol: pathophysiological and clinical approach (author's transl)].
    Pessina AC; Corgnati A; Palù CD
    G Ital Cardiol; 1976; 6(2):290-9. PubMed ID: 1010180
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of beta-blockers on glucose and lipid metabolism.
    Fonseca VA
    Curr Med Res Opin; 2010 Mar; 26(3):615-29. PubMed ID: 20067434
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential changes in lymphocyte beta 2-adrenoceptor density by beta-blocker administration: role of intrinsic sympathomimetic activity.
    Daul A; Wang XL; Borchard U; Bock KD; Brodde OE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S93-6. PubMed ID: 2427860
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The significance of beta1-beta2-selectivity and intrinsic sympathomimetic activity in beta-blockers, with particular reference to antihypertensive treatment.
    Imhof P
    Adv Clin Pharmacol; 1976; 11():26-32. PubMed ID: 25568
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mechanism of beta-blockade hypotension.
    Frohlich ED
    N Engl J Med; 1972 Dec; 287(24):1247-8. PubMed ID: 4404400
    [No Abstract]   [Full Text] [Related]  

  • 69. Role of beta1-3-adrenoceptors in blood pressure control at rest and during tyramine-induced norepinephrine release in spontaneously hypertensive rats.
    Berg T; Piercey BW; Jensen J
    Hypertension; 2010 May; 55(5):1224-30. PubMed ID: 20231523
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Partial regression of vascular structural alterations in hypertensive patients treated with alpha-beta-blocker, labetalol.
    Novo S; Abrignani MG; Sapienza ND; Barbagallo M; Pinto A; Di Maria GU; Mistretta A; Strano A
    Int Angiol; 1992; 11(2):137-41. PubMed ID: 1402218
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The experimental use of calcium antagonists in the treatment of arterial hypertension.
    Lederballe Pedersen O
    Postgrad Med J; 1983; 59 Suppl 2():84-90. PubMed ID: 6136961
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oxygen uptake and plasma catecholamines during submaximal and maximal exercise after long-term beta-receptor blockade.
    Franz IW; Lohmann FW; Koch G
    Int J Sports Med; 1985 Aug; 6(4):202-6. PubMed ID: 2864323
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
    Pettinger WA; Mitchell HC
    N Engl J Med; 1975 Jun; 292(23):1214-7. PubMed ID: 236513
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The relationship between beta-blockade, hyporeninaemic and hypotensive effect of two beta-blocking agents.
    Amery A; De Plaen JF; Fagard R; Linjen P; Reybrouck T
    Postgrad Med J; 1976; 52 Suppl 4():102-8. PubMed ID: 9626
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Beta blockers in hypertension.
    Thadani U
    Am J Cardiol; 1983 Nov; 52(9):10D-15D. PubMed ID: 6139008
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Variability in the preventive action of the B-blockers on genetic hypertension in the rat.
    de Clavière M; Heyndrickx JP; Brotelle R; Colot M
    Paroi Arterielle; 1980; 6(4):227-31. PubMed ID: 6120497
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dissociation of the renin lowering and antihypertensive actions of propranolol.
    Julius S; Esler M; Hansson L; Zwiefler AJ
    Adv Clin Pharmacol; 1976; 11():33-41. PubMed ID: 1032570
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cardiovascular effects of noise.
    Andrén L
    Acta Med Scand Suppl; 1982; 657():1-45. PubMed ID: 6124083
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Activity and number of lymphocyte beta adrenergic receptors after protracted treatment with mepindolol sulfate of patients with essential arterial hypertension].
    Fabris B; De Biasi F; Fischetti F; Leprini R; Castellano M; Carretta R
    G Clin Med; 1990 Nov; 71(11):639-44. PubMed ID: 1964919
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Effect of a beta 2-blocker on the adrenergic receptors of lymphocytes in hypertension].
    Krasnikova TL; Radiukhin VA; Parfenova EV; Suvorov IuI; Ustinova SE
    Biull Eksp Biol Med; 1986 Jul; 102(7):46-8. PubMed ID: 2873850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.